2018 Treatment Algorithm for Breast Ca
The ASCO Post,
Advertisement How should clinicians position anti-HER2 agents and also incorporate endocrine therapies in the treatment of…
Advertisement How should clinicians position anti-HER2 agents and also incorporate endocrine therapies in the treatment of…
Advertisement Ruth O’Regan, MD Given the toxicity of everolimus…as well as the availability of multiple other agents…, it seems…
Un trattamento di prima linea con lapatinib e un taxano non è riuscito a migliorare la sopravvivenza libera da progressione (PFS…